HealthQuill Pharma
Redx Pharma, based in the UK and Jounce Therapeutics, US, will merge in an all-share transaction worth $425 million to establish a new entity focusing on treating cancers and fibrosis.
Drugs Pharma

Redx, Jounce to merge in a $425 million all-share deal

Redx Pharma, based in the UK and Jounce Therapeutics, US, will merge in an all-share transaction worth $425 million to establish a new.

Read More
Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received Breakthrough Therapy Designation from the USFDA.
Drugs Pharma

Moderna-Merck’s cancer vaccine gets FDA breakthrough therapy designation 

Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received.

Read More
Maternal deaths have risen or stagnated globally over recent years, and every two minutes, a woman dies during pregnancy or childbirth, according to the WHO.
Drugs Health Pharma

‘Every two minutes, a woman dies during childbirth, pregnancy’

Maternal deaths have risen or stagnated globally over recent years, and every two minutes, a woman dies during pregnancy or childbirth, according to.

Read More
Merck's COVID-19 pill does not stop the risk of prevention of the virus spreading to others in a household, the company stated.
Drugs Medical Pharma

Merck’s pill fails to prevent COVID-19 infection among households

Merck's COVID-19 pill does not stop the risk of prevention of the virus spreading to others in a household, the company stated.

Read More
India's WiproLab45 unveiled its Decentralized Identity and Credential Exchange (DICE) ID to put the user in control of their medical data, approval to share customer details, and enable citizens to claim government benefits.
Medical Pharma

Wipro unveils ‘tamper-proof’ self-verifiable digital wallet

India's WiproLab45 unveiled its Decentralized Identity and Credential Exchange (DICE) ID to put the user in control of their medical data, approval to.

Read More
Zydus Lifesciences, a subsidiary of Zydus Pharmaceuticals US, has received two tentative FDA approvals, one for treating type 2 diabetes and the other for shingles.
Drugs Pharma

Zydus gets FDA green light for drugs to treat diabetes, shingles

Zydus Lifesciences, a subsidiary of Zydus Pharmaceuticals US, has received two tentative FDA approvals, one for treating type 2 diabetes and the other.

Read More
Apellis Pharmaceuticals, a US-based biopharmaceutical company, has got FDA approval for a drug to treat geographic atrophy, the company announced.
Drugs Medical Pharma

FDA gives nod for Apellis’ injection to treat geographic atrophy

Apellis Pharmaceuticals, a US-based biopharmaceutical company, has got FDA approval for a drug to treat geographic atrophy, the company announced.

Read More
Activation of bio-therapeutic drugs by switching on LEDs embedded close to a tumour may be cancer immunotherapy's future, researchers found.
Drugs Health Pharma

Embedded LEDs may aid future cancer immunotherapies

Activation of bio-therapeutic drugs by switching on LEDs embedded close to a tumour may be cancer immunotherapy's future, researchers found.

Read More
Glenmark Pharmaceuticals, a US-based company, has received a tentative second FDA approval for its oral drug to treat high blood pressure.
Drugs Pharma

Glenmark gets 2nd FDA nod for high blood sugar drug

Glenmark Pharmaceuticals, a US-based company, has received a tentative second FDA approval for its oral drug to treat high blood pressure.

Read More
The WHO has maintained its highest form of alert, the Public Health Emergency of International Concern (PHEIC), on mpox, at its fourth meeting of the international health regulations emergency committee.
Health Pharma

WHO maintains highest public alert on monkeypox

The WHO has maintained its highest form of alert, the Public Health Emergency of International Concern (PHEIC), on mpox, at its fourth meeting.

Read More